What is Ketamine-Assisted Psychotherapy (KAP)?
Understanding Ketamine-Assisted Psychotherapy
Ketamine-Assisted Psychotherapy (KAP) is a breakthrough therapeutic approach that combines the medical administration of ketamine with psychotherapy. Unlike traditional talk therapy alone, KAP uses ketamine's unique pharmacological properties to rapidly alleviate symptoms of depression, anxiety, PTSD, and other mental health conditions, creating a fertile window of neuroplasticity for deep psychological work.
How Does KAP Work?
Ketamine acts on the NMDA receptors in the brain, leading to a surge in glutamate — a key neurotransmitter associated with learning and memory. This surge triggers the release of Brain-Derived Neurotrophic Factor (BDNF), which promotes small synaptic growth. This biological reset often quietens the "Default Mode Network" — the part of the brain associated with rigid, ruminative thought patterns.
With this network temporarily subdued, patients often experience:
- Perspective shifts
- Emotional safety
- Connectedness
The Three Phases of KAP
- Preparation — Establishing safety, setting intentions, and building a trusting relationship with the therapist before the medicine session.
- Journey — The experiential session where ketamine is administered (via lozenge, IM, or IV) under therapeutic supervision.
- Integration — Making sense of the insights gained during the journey and translating them into lasting behavioral changes.
Yale Medicine exploring how ketamine can rapidly relieve symptoms of severe depression.
Is KAP Right For You?
KAP is often recommended for individuals suffering from treatment-resistant depression, severe anxiety, PTSD, or those who feel "stuck" in traditional talk therapy. However, it is not for everyone. Contraindications include a history of psychosis, certain cardiovascular conditions, and active substance use disorders.
Sources & Research
- Sanacora, G., et al. (2017). A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.
- Dore, J., et al. (2019). Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes.
- National Institute of Mental Health (NIMH). Treatment-Resistant Depression research.